Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Manufactured in an ISO 22000 & US FDA Registered Facility
The observed increase (in ALT and AST) is consistent with the moderate, dose-dependent hepatotoxicity documented in rodent models of aminoglycoside exposure
While these effects may be desirable for some users, they also increase the complexity of its safety profile and require careful consideration
It is available in some countries as a prescription peptide or through research chemical suppliers
It is not intended for human consumption, medical use, or veterinary applications
The spheroids treated with Ru(II)-OH, NP2, or NP4 in a 21% O 2 atmosphere primary consisted of dead cells
US$ 27.52
US$ 28.29
US$ 22.91
